Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [11C]CS1P1
Authors:
- 4 June 2019
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 22 (2) , 285-292
Abstract
In preclinical studies with rodent models of inflammatory diseases, [11C]CS1P1 has been identified as a promising imaging agent targeting sphingosine-1-phosphate receptor 1 (S1P1) in the central nervous system and other tissues. In preparation for USA Food and Drug Administration (FDA) approval of [11C]CS1P1 for human use, an acute biodistribution study in mice and an acute tolerability and toxicity evaluation in rats were conducted.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS075527, NS103988)
- National Institute of Biomedical Imaging and Bioengineering (EB025815)
- Mallinckrodt Institute of Radiology, Washington University School of Medicine (#19-014)
This publication has 20 references indexed in Scilit:
- A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injuryJournal of Nuclear Cardiology, 2017
- Sphingosine-1-phosphate receptor 1 transmits estrogens’ effects in endothelial cellsSteroids, 2015
- Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammationNature Immunology, 2013
- Evaluation of [18F]Mefway Biodistribution and Dosimetry Based on Whole-Body PET Imaging of MiceMolecular Imaging and Biology, 2012
- Evaluation and comparison of human absorbed dose of 90 Y-DOTA-Cetuximab in various age groups based on distribution data in ratsJournal of Medical Physics, 2012
- The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulatorsNeurology, 2011
- High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer PatientsThe American Journal of Pathology, 2010
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosisNature Reviews Drug Discovery, 2010
- Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosisPharmacology & Therapeutics, 2008
- The AAPM/RSNA Physics Tutorial for ResidentsRadioGraphics, 2000